P363: A PHASE II STUDY OF FLUMATINIB WITH CHEMOTHERAPY FOR NEWLY DIAGNOSED PH/BCR-ABL1-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA IN ADULTS: UPDATED RESULTS FROM RJ-ALL2020.2A TRIAL
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-08-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000968364.56569.fb |
| _version_ | 1827331331069050880 |
|---|---|
| author | Weiyang Liu Yuanfang Liu Yongmei Zhu Xiangqin Weng Cheng Wang Wanyan Ouyang Jie Xu Jian‑qing MI Jin Wang |
| author_facet | Weiyang Liu Yuanfang Liu Yongmei Zhu Xiangqin Weng Cheng Wang Wanyan Ouyang Jie Xu Jian‑qing MI Jin Wang |
| author_sort | Weiyang Liu |
| collection | DOAJ |
| first_indexed | 2024-03-07T16:34:35Z |
| format | Article |
| id | doaj.art-8a7ddaa9863647109d18a19bee8fe1ca |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T16:34:35Z |
| publishDate | 2023-08-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-8a7ddaa9863647109d18a19bee8fe1ca2024-03-03T10:04:24ZengWileyHemaSphere2572-92412023-08-017e56569fb10.1097/01.HS9.0000968364.56569.fb202308003-00265P363: A PHASE II STUDY OF FLUMATINIB WITH CHEMOTHERAPY FOR NEWLY DIAGNOSED PH/BCR-ABL1-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA IN ADULTS: UPDATED RESULTS FROM RJ-ALL2020.2A TRIALWeiyang Liu0Yuanfang Liu1Yongmei Zhu2Xiangqin Weng3Cheng Wang4Wanyan Ouyang5Jie Xu6Jian‑qing MI7Jin Wang81 Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China1 Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China1 Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China1 Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China1 Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China1 Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China1 Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China1 Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China1 Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Chinahttp://journals.lww.com/10.1097/01.HS9.0000968364.56569.fb |
| spellingShingle | Weiyang Liu Yuanfang Liu Yongmei Zhu Xiangqin Weng Cheng Wang Wanyan Ouyang Jie Xu Jian‑qing MI Jin Wang P363: A PHASE II STUDY OF FLUMATINIB WITH CHEMOTHERAPY FOR NEWLY DIAGNOSED PH/BCR-ABL1-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA IN ADULTS: UPDATED RESULTS FROM RJ-ALL2020.2A TRIAL HemaSphere |
| title | P363: A PHASE II STUDY OF FLUMATINIB WITH CHEMOTHERAPY FOR NEWLY DIAGNOSED PH/BCR-ABL1-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA IN ADULTS: UPDATED RESULTS FROM RJ-ALL2020.2A TRIAL |
| title_full | P363: A PHASE II STUDY OF FLUMATINIB WITH CHEMOTHERAPY FOR NEWLY DIAGNOSED PH/BCR-ABL1-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA IN ADULTS: UPDATED RESULTS FROM RJ-ALL2020.2A TRIAL |
| title_fullStr | P363: A PHASE II STUDY OF FLUMATINIB WITH CHEMOTHERAPY FOR NEWLY DIAGNOSED PH/BCR-ABL1-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA IN ADULTS: UPDATED RESULTS FROM RJ-ALL2020.2A TRIAL |
| title_full_unstemmed | P363: A PHASE II STUDY OF FLUMATINIB WITH CHEMOTHERAPY FOR NEWLY DIAGNOSED PH/BCR-ABL1-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA IN ADULTS: UPDATED RESULTS FROM RJ-ALL2020.2A TRIAL |
| title_short | P363: A PHASE II STUDY OF FLUMATINIB WITH CHEMOTHERAPY FOR NEWLY DIAGNOSED PH/BCR-ABL1-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA IN ADULTS: UPDATED RESULTS FROM RJ-ALL2020.2A TRIAL |
| title_sort | p363 a phase ii study of flumatinib with chemotherapy for newly diagnosed ph bcr abl1 positive acute lymphoblastic leukemia in adults updated results from rj all2020 2a trial |
| url | http://journals.lww.com/10.1097/01.HS9.0000968364.56569.fb |
| work_keys_str_mv | AT weiyangliu p363aphaseiistudyofflumatinibwithchemotherapyfornewlydiagnosedphbcrabl1positiveacutelymphoblasticleukemiainadultsupdatedresultsfromrjall20202atrial AT yuanfangliu p363aphaseiistudyofflumatinibwithchemotherapyfornewlydiagnosedphbcrabl1positiveacutelymphoblasticleukemiainadultsupdatedresultsfromrjall20202atrial AT yongmeizhu p363aphaseiistudyofflumatinibwithchemotherapyfornewlydiagnosedphbcrabl1positiveacutelymphoblasticleukemiainadultsupdatedresultsfromrjall20202atrial AT xiangqinweng p363aphaseiistudyofflumatinibwithchemotherapyfornewlydiagnosedphbcrabl1positiveacutelymphoblasticleukemiainadultsupdatedresultsfromrjall20202atrial AT chengwang p363aphaseiistudyofflumatinibwithchemotherapyfornewlydiagnosedphbcrabl1positiveacutelymphoblasticleukemiainadultsupdatedresultsfromrjall20202atrial AT wanyanouyang p363aphaseiistudyofflumatinibwithchemotherapyfornewlydiagnosedphbcrabl1positiveacutelymphoblasticleukemiainadultsupdatedresultsfromrjall20202atrial AT jiexu p363aphaseiistudyofflumatinibwithchemotherapyfornewlydiagnosedphbcrabl1positiveacutelymphoblasticleukemiainadultsupdatedresultsfromrjall20202atrial AT jianqingmi p363aphaseiistudyofflumatinibwithchemotherapyfornewlydiagnosedphbcrabl1positiveacutelymphoblasticleukemiainadultsupdatedresultsfromrjall20202atrial AT jinwang p363aphaseiistudyofflumatinibwithchemotherapyfornewlydiagnosedphbcrabl1positiveacutelymphoblasticleukemiainadultsupdatedresultsfromrjall20202atrial |